Embed Size (px)
DESCRIPTION
Medicines Transparency Alliance How has MeTA Peru undertaken this issue El Observatory of Prices is a component in the workplan of MeTA Peru. Production of a regulatory proposal with participation of associates to develop the Observatory. Deliverable of a regulatory proposal by MeTA Peru to the Ministry of Health for approval. Technological Support: Software and IT. Diffusion of the Observatory of Prices among the population. 02/02/20163
Citation preview
Medicines Transparency Alliance03/05/23 1
MeTA PeruPedro Yarasca
System of public information on prices of Pharmaceutical Products
Medicines Transparency Alliance03/05/23 2
Analysis of the pricing situation in Peru
0
1
2
3
4
5
6
7
8
0
20
40
60
80
100
120
140
160
180
Prec
io P
rom
edio
US$
Mill
ones
de
Uni
dade
sPERUVIAN PHARMACEUTICAL MARKET1969-2009
RETAIL MARKETUnits vs. Average Price
unidades Precio Promedio
CIPROFLOXACINO 500MG TABLETAS DISPERSION DE PRECIOS EN EL MERCADO FARMACEUTICO TOTAL
8.28
10.39
0.063
7.91
6.245.82
1.101.30 1.53
1.911.60
2.74
3.54 3.57 3.744.16
4.60
0.8340.6260.5630.3500.1960.1910.1680.1570.1460.144 0.196 0.263 0.270 0.274 0.294 0.337
0.00
2.00
4.00
6.00
8.00
10.00
Marca Génerico Público
Medicines Transparency Alliance
How has MeTA Peru undertaken this issue
El Observatory of Prices is a component in the workplan of MeTA Peru.
Production of a regulatory proposal with participation of associates to develop the Observatory.
Deliverable of a regulatory proposal by MeTA Peru to the Ministry of Health for approval.
Technological Support: Software and IT. Diffusion of the Observatory of Prices among the
population.
03/05/23 3
Medicines Transparency Alliance
National Information System of Pharmaceutical PricesObjectives:To establish an information system that contribute to prevent monopolistic practices and segmentation of the market.To guarantee transparency of sales prices information that allows to adopt informed decisions in favour of users.
Legal Framework: Ley Nº 29459 Law of Pharmaceutical Products, medical devices and sanitary products. RM Nº 040-2010/MINSA (17.01.2010) RM Nº 157-2010/MINSA, modification of Art. 4° de RM N° 040-2010/MINSA (26.02.2010)
Medicines Transparency Alliance
REACHAll pharmaceutical establishments, public and private (laboratories, drug stores, pharmacies and chemist’s shops) should be registered in the National System of Information of Prices of Pharmaceutical Products (SNIP-PF) by of the Regulating Authority of Medicines in charge - DIGEMID.
Laboratories
Drugstores
Pharmacies
Chemist’s Shops
Public,Private, orMixed
Observatory of Prices of Pharmaceutical Products
Medicines Transparency Alliance
TYPE OF INFORMACIÓN
Laboratories
Drugstores
Pharmacies
Chemist’s Shops
Retail Prices (including discounts)
Maximum Prices
Minimum Prices
Average Price
Reporting frequency: At least once a month
Observatory of Prices of Pharmaceutical Products
Medicines Transparency Alliance
DATES
R.M. Nº 040-2010/MINSA
Pharmaceutical Product Catalog
FINAL Software
Pharmaceutical Establishments report the prices
July, 2010
May, 2010
August, 2010
Observatory of Prices of Pharmaceutical Products
Medicines Transparency Alliance
Observatory of Prices of Pharmaceutical ProductsVersion 2 (now)
Price consultation process
Factor:Substance, pharmaceutical form, geographical zone
IMS
SISMED
Database
Filter:Disponibility of Stock: 2 months
Study:
Estimation of the marketing margins
www.minsa.gob.pehttp://observatorio.digemid.minsa.gob.pe
Medicines Transparency Alliance03/05/23 9
Thank you
Pedro Yarasca
e-mail: [email protected]
Telf.: 0051-1-998704127
www.digemid.minsa.gob.pe
